Development of a syringe/sonication device employed to administer DDFPe in the prehospital setting
Award amount
$143,988Program and phase
SBIR · Phase IAward year
2018Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NUVOX PHARMA, L.L.C.
- Proposal award date
- 2017-12-01
- Contract end date
- 2019-05-31
- UEI
- WHNYG96UDLJ8
- Solicitation number
- PA16-302
- Topic code
- 101
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Liquid Biopsy in Glioblastoma Treated with Chemoradiation and an Oxygen Therapeutic
- Dodecafluoropentane emulsion (DDFPe), NanO2™ as Cerebroprotectant in Ischemic Stroke
- NanO2 as a Cerebroprotectant in a tMCAO Stroke Model in Mice
- Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
- Dodecafluoropentane Prevents Ischemia Reperfusion Injury in Contemporary Acute Myocardial Infarction Management
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- High bandwidth all-optical electrophysiology
- Fast multicolor confocal fluorescence imager for neural network mapping
- Advanced culture and recording system for long-term electrophysiological profiling in human brain organoids
- Commercialization Readiness for a Portable PET Insert System for Simultaneous TOF-PET and MR Brain Imaging
- Design and Development of an Advanced Functional MRI Software as Medical Device (SaMD) forClinical Trials and Therapeutic Applications in Neuropsychiatry
Research funding history
12 SBIR/STTR records share this UEI (2010–2025). Reported award amounts total $8,518,151. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services